Literature DB >> 25573929

Genome sequence of a novel recombinant coxsackievirus a6 strain from shanghai, china, 2013.

Xiaobo Feng1, Wencai Guan2, Yifeng Guo1, Huiju Yu3, Xiaoling Zhang2, Ruhong Cheng1, Zhen Wang1, Zhen Zhang1, Jia Zhang1, Huaguo Li1, Yin Zhuang1, Hui Zhang1, Zhiyong Lu1, Ming Li1, Hong Yu1, Yixiao Bao3, Yunwen Hu4, Zhirong Yao5.   

Abstract

A novel recombinant coxsackievirus A6 (CVA6) strain was isolated during a coxsackievirus A6 outbreak in Shanghai, China, in 2013. Genomic sequence and similarity plot analysis showed that the novel CVA6 strain shared higher similarity with a recent CVA4 strain rather than the recent CVA6 strain in the 2C and 3' untranslated regions (UTRs).
Copyright © 2015 Feng et al.

Entities:  

Year:  2015        PMID: 25573929      PMCID: PMC4290982          DOI: 10.1128/genomeA.01347-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Coxsackievirus A6 (CVA6) belongs to the human enteroviruses species A (EV-A), genus Enterovirus, family Picornaviridae. Enterovirus infections resulted in a variety of diseases, such as hand-foot-month disease (HFMD). However, CVA6 gradually emerged and caused specially generalized exanthema in HFMD cases reported since 2008 (1–3). Although the prototype CVA6 strain isolated in 1949 has been available online since 2004, the recent CVA6 outbreak strain shizuoka18 isolated from Japan in 2011 was published in 2012 (4). CVA6 outbreaks have been detected in China since late 2012 (5–8), and a novel recombinant CVA6 strain was isolated and identified from the throat swabs of CVA6-positive specimens during this outbreak in Shanghai, China, in 2013. To obtain the complete genome sequence of this novel CVA6 virus, viral RNA of a representative strain (PF1/SH/CHN/2013) was extracted from the culture of a rhabdomyosarcoma (RD) cell using a QIAamp viral RNA minikit (Qiagen, Santa Clara, CA). Overlapping fragments covering the viral genome were amplified using a one-step reverse transcription (RT)-PCR kit (TaKaRa), and the primers were designed mainly based on the recent CVA6 (GenBank accession no. AB678778) and CVA4 (GenBank accession no. HQ728260) genome sequences published in the previous studies (4, 9). The PCR products were purified and then sequenced on an automated sequencer ABI 3730 (Applied Biosystems, Foster City, CA). The sequenced DNA fragments were assembled into complete genomes using the ContigExpress project in Vector NTI version 11.5. The whole-genome sequence of the novel recombinant CVA6 was 7,433 nucleotides (nt) long. A long single open reading frame was characterized. The polyprotein-coding sequence is 6,606 nt long and contains 2,201 codons. The 5′ and 3′ untranslated regions (UTRs) are 746- and 81-nt long, respectively. Compared with the recent CVA6 genome sequence (GenBank accession no. AB678778), a 1-nt deletion in the 5′ UTR and 697-nt differences with 51 amino acid changes in the coding region were found. Similarity plot analysis based on the whole genomes revealed that the 5′ UTR, P1 region, and partial P2 region (2A) were highly conserved between this novel CVA6 and recent CVA6 sequences, with at least 94.2% nucleotide sequence identity. However, in the 2C and 3′ UTR regions, the novel CVA6 strain shared high similarities of 91.0% to 93.5% with a recent CVA4 strain circulating in Shanghai. This study suggests the necessity of continuous monitoring of genetic recombination of more current CVA6 and other serotypes and provides a public health warning for possible outbreaks in the future.

Nucleotide sequence accession number.

The genome sequence of the novel recombinant CVA6 strain has been deposited in GenBank under the accession no. KJ612513.
  9 in total

1.  Hand, foot, and mouth disease outbreak caused by coxsackievirus A6, China, 2013.

Authors:  Jian-Feng Han; Shuang Xu; Yu Zhang; Shun-Ya Zhu; Dong-Lin Wu; Xian-Da Yang; Hong Liu; Bing-Xin Sun; Xiao-Yan Wu; Cheng-Feng Qin
Journal:  J Infect       Date:  2014-04-02       Impact factor: 6.072

2.  Complete genome analysis of coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A.

Authors:  Y F Hu; Fan Yang; J Du; J Dong; T Zhang; Z Q Wu; Y Xue; Qi Jin
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

3.  Hand, foot and mouth disease caused by coxsackievirus A6, Beijing, 2013.

Authors:  Gu Hongyan; Ma Chengjie; Yang Qiaozhi; Hua Wenhao; Li Juan; Pang Lin; Xu Yanli; Wei Hongshan; Li Xingwang
Journal:  Pediatr Infect Dis J       Date:  2014-12       Impact factor: 2.129

4.  Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China.

Authors:  Ya-Qing He; Long Chen; Wen-Bo Xu; Hong Yang; Han-Zhong Wang; Wen-Ping Zong; Hui-Xia Xian; Hui-Ling Chen; Xiang-Jie Yao; Zhang-Li Hu; Min Luo; Hai-Long Zhang; Han-Wu Ma; Jin-Quan Cheng; Qian-Jin Feng; De-Jian Zhao
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

5.  An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010.

Authors:  Sung-Hsi Wei; Yuan-Pin Huang; Ming-Chih Liu; Tsung-Pei Tsou; Hui-Chen Lin; Tsuey-Li Lin; Chen-Yen Tsai; Yen-Nan Chao; Luan-Yin Chang; Chun-Ming Hsu
Journal:  BMC Infect Dis       Date:  2011-12-14       Impact factor: 3.090

6.  Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011.

Authors:  Tsuguto Fujimoto; Setsuko Iizuka; Miki Enomoto; Katsuhiko Abe; Kazuyo Yamashita; Nozomu Hanaoka; Nobuhiko Okabe; Hiromu Yoshida; Yoshinori Yasui; Masaaki Kobayashi; Yoshiki Fujii; Hiroko Tanaka; Miwako Yamamoto; Hiroyuki Shimizu
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

7.  Coxsackievirus A6 and hand, foot, and mouth disease, Finland.

Authors:  Riikka Osterback; Tytti Vuorinen; Mervi Linna; Petri Susi; Timo Hyypiä; Matti Waris
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

8.  Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities.

Authors:  Yi-Jen Chen; Shih-Cheng Chang; Kuo-Chien Tsao; Shin-Ru Shih; Shu-Li Yang; Tzou-Yien Lin; Yhu-Chering Huang
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

9.  Circulation of Coxsackievirus A6 in hand-foot-mouth disease in Guangzhou, 2010-2012.

Authors:  Biao Di; Ying Zhang; Huaping Xie; Xiaoquan Li; Chun Chen; Peng Ding; Peng He; Dahu Wang; Jinmei Geng; Lei Luo; Zhijun Bai; Zhicong Yang; Ming Wang
Journal:  Virol J       Date:  2014-09-01       Impact factor: 4.099

  9 in total
  2 in total

1.  Divergent Pathogenic Properties of Circulating Coxsackievirus A6 Associated with Emerging Hand, Foot, and Mouth Disease.

Authors:  Shao-Hua Wang; Ao Wang; Pan-Pan Liu; Wen-Yan Zhang; Juan Du; Shuang Xu; Guan-Chen Liu; Bai-Song Zheng; Chen Huan; Ke Zhao; Xiao-Fang Yu
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

2.  Development and evaluation of a non-ribosomal random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot and mouth disease pathogens.

Authors:  Anh To Nguyen; Thanh Tan Tran; Van Minh Tu Hoang; Ngoc My Nghiem; Nhu Nguyen Truc Le; Thanh Thi My Le; Qui Tu Phan; Khanh Huu Truong; Nhan Nguyen Thanh Le; Viet Lu Ho; Viet Chau Do; Tuan Manh Ha; Hung Thanh Nguyen; Chau Van Vinh Nguyen; Guy Thwaites; H Rogier van Doorn; Tan Van Le
Journal:  Virol J       Date:  2016-07-07       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.